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Introduction
This publication is a continuation of the document entitled
"Multimodality Imaging Training Curriculum — General
Recommendations" which was published in the ESR journal
Insights into Imaging (Insights Imaging 2(2): 99–101, DOI:
10.1007/s13244-011-0067-6) and inEJNMMI (DOI10.1007/
s00259-011-1804-2).
The following sections of the document (Part II and III) list
specific knowledge requirements for appropriate training in
multimodality imaging for those whose background is in
nuclear medicine and radiology respectively (PET/CT,
SPECT/CT).
Apart from specified training items it is understood that prac-
tising multimodality imaging requires certain skills above and
beyond those enumerated under specific pathology areas.
These include knowledge of emergency imaging findings as
relevant to each specific organ system (BK0Basic Knowl-
edge), interpretation and management of unexpected findings
in the imaging of each organ system (CS0Core Skills), an
understanding of the process of justification of requests for
imaging investigation and appropriateness criteria (CS), crea-
tion of a structured, coherent, and clinically relevant imaging
report (CS), an understanding of the medico-legal implication
of imaging practice (CS), basics of oncogenesis including
elements of cell biology and genetics (BK), principles of
systemic, regional and targeted therapies (BK), principles
and application of screening methodologies (BK).
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Nuclear Medicine Curriculum for those whose
Training Background is in Radiology
Preamble to Part II
In 2011 the “Multimodality Imaging Training Curriculum –
General Recommendations” were published in the EJNMMI
(Eur J Nucl Med Mol Imaging DOI 10.1007/s00259-011-
1804-2)a n di nInsights into Imaging (Insights Imaging 2(2):
99-101, DOI: 10.1007/s13244-011-0067-6). Both the Europe-
an Association of Nuclear Medicine and the European Society
of Radiology committed themselves to writing more detailed
recommendations regarding skills and knowledge require-
ments for nuclear medicine physicians in radiology and radi-
ologistsinnuclearmedicine.PartsII& IIIoftheMultimodality
Imaging Training Curriculum were endorsed by the ESR Ex-
ecutive Council in June 2011, as well as the EANM Executive
Committee, the EANM Advisory Council and on February 26,
2012 by the extraordinary EANM Delegates Assembly.
The Multimodality Imaging Training Curriculum is a
joint European initiative between the EANM and the ESR
to define the scope of training for medical specialists in
hybrid imaging. The curriculum is a framework outline that
may be used by member societies where appropriate to form
the basis for discussion on the optimisation of further train-
ing of medical specialists.
This curriculum cannot be used to legally justify changes
to the organisation, overall specialist training or reimburse-
ment regulations in any member state.
Nuclear Medicine Curriculum for those whose
Training Background is in Radiology
The following outlines a check list of nuclear medicine training
requirements for radiologists to ensure the appropriate level of
knowledge is obtained for performing and reading hybrid im-
aging such as PET/CTand SPECT/CTwithin a 2-year training
period. This checklist differentiates three levels of competence:
basic knowledge (BK), detailed knowledge (DK) and core
skills (significant practical experience required, CS).
A. Required general training in nuclear medicine
Production and properties of radionuclides (BK)
The production of radionuclides by cyclotrons, radionuclide
generators and reactors
The production of PET nuclides by cyclotrons and radionu-
clide generators
Practical issues related to the use of short-lived radionuclides
Practical issues related to the use of generators to produce
radionuclides
The physical properties of commonly used diagnostic radio-
nuclides (physical half-life, photon energy)
Tracer principles and techniques (BK)
The basic principles of tracer studies
The kinetics of radioactive tracers used in nuclear medicine
The use of principles of kinetics and modelling techniques
to calculate parameters such as glomerular filtration rate
Errors associated with quantitative measurements
Radiopharmacy
The principles of localisation of radiopharmaceuticals (BK)
Different formulations used in nuclear medicine (BK)
Cell labelling techniques (BK)
The physicochemical and biological properties of different
radiopharmaceuticals in routine clinical practice (biological
half-life, biokinetics, dosimetry) (DK)
Legislation
Regulations relating to radiation protection (DK)
Specific regulations relating to the use of radionuclides (DK)
Specific regulations relating to the manufacture of radio-
nuclides (BK)
National and international regulatory requirements for the
practice of nuclear medicine (BK)
Radiopharmaceutical transport (BK)
Waste disposal (BK)
Instrumentation
Nuclear medicine equipment (BK)
Principles of gamma camera and PET systems (DK)
Nuclear physics (BK)
Radiation protection and other safety issues (DK)
B. Specific studies by organ
Understanding of the role of nuclear medicine procedures in
the clinical management of the relevant disease entities and
the various protocols used (DK)
Understanding of the complementary imaging studies and
the appropriate use of the various procedures in the manage-
ment of patients (DK)
Normal anatomy, physiology and pathophysiology (BK)
Musculoskeletal (DK)
Benign bone disease (fractures, osteomyelitis, Paget's dis-
ease, fibrous dysplasia, sport injuries)
Malignant bone disease (primary and secondary)
Joint disease (arthritis, infected joints, infected prostheses)
Bone marrow studies
Understanding of the role of SPECT/CT in addition to
planar scintigrams and of PET/CT using FDG, F-18- fluo-
ride and other relevant agents commonly used in musculo-
skeletal diseases
Patient preparation and procedural aspects depending on the
clinical question, e.g. three-phase imaging
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Ventilation/perfusion imaging for the diagnosis of pulmo-
nary thromboembolism (DK)
Differential pulmonary lung function studies (BK)
Mucociliary clearance studies (BK)
Lung permeability studies (BK)
GI tract (BK)
Salivary gland imaging
Oesophageal and intestinal transit studies
Meckel's diverticulum studies
Radiolabelled red blood cell studies (GI bleeding, liver
haemangioma)
Liver RES scintigraphy (both dynamic and static studies)
Hepatobiliary studies
Inflammatory bowel disease
Understanding of the role of breath tests in the investigation
of malabsorption
Urogenital tract (BK)
Dynamic renography (differential and absolute function, di-
lated outflow tract, obstruction, renovascular hypertension)
DMSA studies (pyelonephritis, ectopic kidneys, differential
function)
GFR and ERPF measurement (blood and urine samples,
computer-based techniques)
Indirect and direct cystourethrography
Understanding of related general issues, e.g. concurrent
medication and preparation of the patient for the study,
including the use of pharmaceutical interventions (e.g.
ACEI, AT receptor blockade, furosemide)
Endocrine (BK)
Benign thyroid disease, thyrotoxicosis, thyroid nodules
Interaction of agents such as amiodarone, iodine and drugs
used to treat thyroid disease with radiopharmaceuticals
Malignant thyroid disease (understanding of the role of
radio-iodine)
Parathyroid disease (understanding of the role of MIBI and
SPECT/CT)
Neuroendocrine tumours (understanding of the role of
SPECT/CT, if required in addition to planar imaging, and
of PET/CT)
Adrenal imaging
Lymphatic system
Lymphoedema studies (BK)
Sentinel lymph node identification (breast, melanoma, head
and neck, urogenital tumours) (DK)
Lymphatic leaks (BK)
Infection/inflammation (DK)
Processes involved in infection/inflammation
Understanding of the clinical role of different tracers in:
Bone scintigraphy (multiphase imaging)
HMPAO WBCs
Indium WBCs
Gallium citrate
Antigranulocyte antibodies (intact and fragments)
FDG
Understanding the role of SPECT/CT, if required in addition
to planar imaging, and of PET/CT
Oncology (DK)
Understanding of tumour biology
Understanding of the clinical indications for the various
tracers used:
Radiolabelled antibodies
Pentavalent DMSA
Peptides
MIBG
MIBI
FDG
Other PET tracers
Understanding of the role of PET/CT and of SPECT/CT, if
required in addition to planar imaging, in tumour imaging
Paediatrics
Normal anatomy and physiology to include knowledge of
growth and maturation (BK)
Specific uses of nuclear medicine in paediatrics (BK)
Special precautions/protocols/legislation used in paediatrics
(sedation, immobilisation, scintigraphic techniques) and ad-
justment of administered activities (DK)
Understanding specific issues in children such as immobili-
sation and radioprotection (DK)
C. Topics specific to PET/CT
Understanding of general issues related to preparation of the
patient for the study (DK)
Oncology
Tumour metabolism (DK)
The specific patterns of spread for the various tumours (DK)
Normal distribution of F-18-FDG, C-11 and F-18 choline,
C-11 methionine, NaF-18 and Ga-68 peptides (DK) The
patterns of non-malignant disease including thyroid nodules,
muscle uptake, brown fat, ovarian uptake, benign tumours,
infection, inflammation and other potential pitfalls (CS)
Specific uses of FDG PET (CS):
Lung cancer
Lymphoma
Bowel cancer
Malignant melanoma
Oesophagus/stomach cancer
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Cervical/ovarian cancer
Cancer of unknown primary
Sarcoma
Thyroid cancer
Breast cancer
Pancreatic cancer
Renal cancer
Testicular tumours
GIST
Non-malignant uptake associated with the above tumours: (CS)
Infection
Sarcoid
Inflammation (reflux oesophagitis, rheumatoid
joint disease, seronegative spondylarthropathies,
tonsillitis, surgical wounds, post-radiotherapy)
Thymic rebound
Recurrent laryngeal nerve palsy
Bone marrow uptake after chemotherapy
Malignancies in which FDG-PET has a limited role (low-
grade malignancies) (DK)
Specific uses of C-11 and F-18-choline in prostate cancer (DK)
Specific uses of C-11 methionine, F-18 FET and FDG in
brain tumours (BK)
Specific uses of Ga-68 peptides and F-18 FDOPA in neuro-
endocrine tumours (BK)
The role of PET in detection, staging, follow-up and
assessment of recurrence, and the relation of PET/CT to
other imaging investigations (CS)
Specific protocols used in the different types of cancer (time
of image acquisition, anatomical field to be examined, arms
up or down, medication etc.) (CS)
Response assessment in the various tumours and expected pat-
terns according to the applied treatment (surgery, radio-
therapy, chemotherapy, targeted therapy) (CS)
Benign indications (CS)
Specific uses of FDG PET in infection and inflammation
(vascular, musculoskeletal, fever of unknown origin, gran-
ulomatous diseases)
PART III
Radiology Curriculum for those whose Training
Background is in Nuclear Medicine
Preamble to Part III
In 2011 the “Multimodality Imaging Training Curriculum
– General Recommendations” were published in the
EJNMMI (Eur J Nucl Med Mol Imaging DOI 10.1007/
s00259-011-1804-2)a n di nInsights into Imaging (Insights
Imaging 2(2): 99-101, DOI: 10.1007/s13244-011-0067-6).
Both the European Association of Nuclear Medicine and
the European Society of Radiology committed themselves
to writing more detailed recommendations regarding skills
and knowledge requirements for nuclear medicine physi-
cians in radiology and radiologists in nuclear medicine.
Parts II & III of the Multimodality Imaging Training
Curriculum were endorsed by the ESR Executive Council
in June 2011, as well as the EANM Executive Committee,
the EANM Advisory Council and on February 26, 2012
by the extraordinary EANM Delegates Assembly.
The Multimodality Imaging Training Curriculum is a joint
Europeaninitiative between the EANM and the ESRtodefine
thescope oftrainingfor medicalspecialistsinhybridimaging.
The curriculum is a framework outline that may be used by
member societies where appropriate to form the basis for
discussion on the optimisation of further training of medical
specialists.
This curriculum cannot be used to legally justify changes
to the organisation, overall specialist training or reimburse-
ment regulations in any member state.
Radiology Curriculum for those whose Training
Background is in Nuclear Medicine
The following outlines a check list of radiology training for
nuclear medicine physicians to ensure the appropriate level of
knowledge is obtained for performing and reading hybrid
imaging such as PET/CT and SPECT/CT within a two years
training period. This checklist differentiates three levels of
knowledge: basic knowledge (BK), detailed knowledge (DK),
and core skills (significant practical experience required, CS).
A. Required general training in radiology
a. Principles of imaging technology as applied to diagnos-
tic radiology (radiation physics) (BK)
b. Radiobiology (BK)
c. The physical basis of image formation including con-
ventional x-ray, computed tomography, magnetic reso-
nance imaging (DK)
d. Radiographic quality control (DK)
e. Radiation protection (DK)
f. Anatomy, normal variants, pathological features, physi-
ology, biochemistry and techniques related to radiolog-
ical procedures (BK)
g. Cell biology, DNA, RNA, and cell activity (BK)
h. Clinical indications for the administration of intrave-
nous and oral contrast media (BK)
i. Basic principles of image acquisition and post-processing
to include MPR, MIP and volume rendering principles;
understanding of concepts of data acquisition in CT tech-
nology and volumetric CT data acquisition; knowledge of
detector composition and physics, CT numbers and
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andcontrastresolution;familiaritywithmajorCTartefacts
including motion, streak, beam hardening and ring arte-
facts (DK)
j. Basicunderstandingofcomputerscience,imagearchiving
and image communication and teleradiology (BK)
k. Clinical Application and Study Protocols to include:
an understanding of patient preparation for PET/CT
examinations, venous access and principles of the
use of beta-blocking when appropriate (DK)
l. Intravascular contrast media to include pharmacolo-
gy, osmolar types, potential vascular toxicity, soft
tissue toxicity, cardiovascular toxicity, neurotoxicity,
nephrotoxicity and effects on thyroid function tests.
A knowledge of idiosyncratic reactions to include
incidence, distinction of minor, intermediate and
major reactions, mechanisms of idiosyncratic reac-
tions and principles of prophylaxis for adverse reac-
tions to contrast media
B. Specific studies by organ
Musculoskeletal systems
Musculoskeletal anatomy, normal variants which may mim-
ic disease and radiological appearances of common congen-
ital dysplasias (BK)
Radiologic appearances of common arthropathies (BK)
Degenerative disorders and their clinical relevance (DK)
Manifestations of musculoskeletal infection, inflammation
and metabolic diseases including osteoporosis and bone
densitometry (DK)
Recognition, staging and surveillance of bone and soft-
tissue tumours and haemotological disorders (DK)
Reporting CT and MR of common musculoskeletal disor-
ders (CS)
Managing and reporting CT and MR of musculoskeletal
trauma (BK)
Thorax
Features on CT and differential diagnosis of atelectasis and
diffuse lung disease (DK)
Mediastinal and hilar lymph nodes: normal appearance,
normal dimensions, causes of calcification, radiological fea-
tures of adenopathy on CT to include size criteria, features
of reactivity and lymphatic drainage pathways, knowledge
of American Thoracic Society lymph node location nomen-
clature (CS)
Features of pneumothorax including: evidence of tension,
pneumomediastinum etc (BK)
Solitary and multiple pulmonary nodules: definition, recogni-
tion of micronodular, nodular, macronodular and cavitating
nodular lung, disease with differential diagnosis, understand
role of radiology in follow-up lung nodule, features of benig-
nity within pulmonary nodules (CS)
Protocols for evaluation for single and multiple pulmonary
nodules (DK)
Malignant neoplasms of the lung, including knowledge of:
histological types, TNM, features of recurrent tumour post
treatment or surgery (CS)
The manifestations and role of imaging in thoracic lympho-
ma (CS)
Interpretation of high resolution thoracic CT specifically
with reference to diffuse lung disease and exclusion of
opportunistic lung disease (CS)
Recognition of features of pulmonary embolism on CT/
PA (CS)
Gastrointestinal
Knowledge of radiologic appearances in viscous perfora-
tion, inflammation, infection, obstruction, ischaemia and
infarction on plain radiographs, contrast studies, and CT
(BK)
Role of ultrasound and relevant ultrasound features in bili-
ary tract and parenchymal solid organ disease (BK)
Imaging features and differential diagnosis of primary and
secondary tumours of the solid organs, oesophagus, stom-
ach, small bowel, colon and rectum (DK)
Imaging features of the stage and extent of tumours
including features which indicate unresectability and
knowledge of the role of endoscopy and endoscopic
US (DK)
Radiological manifestations of inflammatory bowel dis-
eases, malabsorption syndrome and infection (BK)
Recognition of motility disorders, hernias and diverticula (BK)
Radiological manifestation of vascular lesions including
varices, ischaemia, infarction, haemorrhage and vascular
malformations (BK)
An understanding of the role of CT colonoscopy (BK)
Understanding of the applications of angiography, vascular
interventional techniques, stenting and portosystemic decom-
pression procedures (BK)
Tumours, infectious and degenerative lesions of the
liver (DK)
Managing and reporting CT of the abdomen (CS)
Experience of the manifestations of abdominal disease on
MRI (CS)
Urogenital
Understanding of renal function, the diagnosis of renal
parenchymal diseases including infection and renovascular
disease and management of renal failure (BK)
Imaging features and appropriate investigation of calculus
disease (BK)
Investigation and features of urinary tract obstruction and
reflux (BK)
Imaging features and differential diagnosis of tumours of the
kidney and urinary tract (DK)
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the retroperitoneum, prostate and testis (DK)
Managing and reporting computed tomography and MR
imaging of the retroperitoneum, urinary tract and pelvis (CS)
Interventional radiology and vascular system
A knowledge of the role of interventional techniques specifical-
ly with reference to procedures such as tumour biopsy, embo-
lisation, biliary drainage, pleural effusion aspiration etc. (BK)
A knowledge of radiological methods related to the vascular
and lymphatic system (BK)
Paediatric
Normal paediatric anatomy and normal variants with partic-
ular focus on normal maturation and growth (BK)
Disease entities specific to the paediatric age group and their
clinical and radiological manifestations using all potential imag-
ing investigations (BK)
The value and indications for CT and MR in children (DK)
Disorders and imaging features of the neonate (BK)
Managing and reporting CT and MR examinations (CS)
Detailed knowledge of ALARA principle and its application in
a paediatric population (BK)
Particular benefits of ultrasound in evaluation of disease in
the paediatric population (BK)
Knowledge of benign disease which may mimic malig-
nancy (DK)
Head and neck
Knowledge of normal anatomy and variants of facial bones
and paranasal sinus anatomy (BK)
Features of benign disease of mandible and maxilla which
mimic malignancy disease (DK)
Diagnosis of faciomaxillary trauma and tumours (DK)
Radiology of disorders of thyroid, parathyroid glands
and complementary evaluation with nuclear medicine
techniques (BK)
Role of intravenous contrast radiology in evaluation of head
and neck pathology (CS)
Imaging features of trauma, inflammation, infection and
tumours of the paranasal sinuses, oral cavity, larynx and
pharynx (DK)
Managing and reporting CT and MR of neck, ear, nose,
throat and skull base disorders (CS)
Gynaecology and obstetrics
Imaging features of disorders of the ovaries, uterus and
vagina as demonstrated on CT and MR (BK)
Awareness of specific benefits of ultrasound in evaluation and
interventional technique for gynaecologic malignancy (BK)
Awareness of the applications of angiography and vascular
interventional techniques (BK)
Oncology
Tumour classification and staging nomenclature (DK)
Application of all imaging and interventional techniques in
staging and monitoring the response of tumours to therapy(DK)
Knowledge of expected radiologic change in response to
therapy (DK)
Radiological manifestations of complications in tumour
management (DK)
Performing and reporting CT, and MR to assess tumours and
response to therapy (CS)
Principles of communication as described in Part I of this
document (EJNMMI 38: 976–978; DOI 10.1007/s00259-
011-1804-2)
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